There is a shortage of clinicians authorized to prescribe medications to treat opioid use disorder.1,2 Nurse practitioners (NPs) and physician assistants (PAs) were allowed to obtain waivers to prescribe buprenorphine beginning in 2016.3,4 We investigated the proportions of NPs and PAs with waivers in 2018 and the association with state regulations that restrict their scope of practice.
Spetz J, Toretsky C, Chapman S, Phoenix B, Tierney M. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions. JAMA. 2019;321(14):1407–1408. doi:10.1001/jama.2019.0834
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: